Skip to main content
. 2018 Nov 2;2(Suppl 1):S81–S91. doi: 10.1093/jcag/gwy057

Table 2.

IBD research funding in Canada (2013 to 2017)*

Funder Year Total
2013 2014 2015 2016 2017
CIHR $11,010,425 $10,897,649 $12,893,535 $14,278,583 $16,867,707 $65,947,899
CCC $5,283,966 $7,567,053 $6,002,125 $6,583,829 $6,694,961 $32,131,934
NAPHRO $6,842,040 $4,128,397 $1,500,941 $1,413,121 $2,646,921 $16,531,420
Genome $161,996 $647,985 $647,985 $647,985 $772,985 $2,878,935
CFI $0 $0 $105,033 $125,000 $572,960 $802,993
NSERC $43,990 $90,990 $106,500 $162,000 $102,500 $505,980
CRS $60,000 $60,000 $120,000 $80,000 $100,000 $420,000
CCS $112,800 $77,000 $60,000 $59,700 $39,400 $348,900
SSHRC $0 $0 $0 $17,500 $0 $17,500
$23,515,217 $23,469,073 $21,436,119 $23,367,718 $27,797,434 $119,585,561

* in CAD

Abbreviations: CCC: Crohn’s and Colitis Canada; CCS: Canadian Cancer Society; CFI: Canada Foundation for Innovation; CRS: Cancer Research Society; Genome: Genome Canada; NAPHRO: National Alliance of Provincial Health Research Organizations; NSERC: Natural Sciences and Engineering Research Council of Canada; SSHRC: Social Sciences and Humanities Research Council